Literature DB >> 2497921

Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism.

Y Fujii1, J Sakurai.   

Abstract

1. Alpha toxin produced by Clostridium perfringens contracted the rat isolated aorta and stimulated release of arachidonic acid in the tissue. 2. Quinacrine did not inhibit contraction caused by the toxin. 3. Indomethacin blocked contraction caused by the toxin in a dose-dependent manner and markedly increased levels of arachidonic acid released by the toxin. 4. The toxin-induced contraction was blocked by the thromboxane synthetase inhibitor OKY-046 and the thromboxane A2 (TXA2) antagonist ONO-3708. 5. The toxin stimulated production of TXB2 and this was blocked by pretreatment with either indomethacin or OKY-046. 6. Toxin-induced contraction was diminished by pretreating aorta with collagenase or by rubbing the intimal surface to remove the endothelium. 7. These data suggest that the contractile response to the toxin is associated with stimulation of TXA2 production from arachidonic acid released by the toxin in the endothelial cells of the aorta.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497921      PMCID: PMC1854495          DOI: 10.1111/j.1476-5381.1989.tb11931.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries.

Authors:  N Toda; M Nakajima; T Okamura; M Miyazaki
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

2.  Effect of Clostridium perfringens alpha toxin on the isolated rat vas deferens.

Authors:  J Sakurai; S Nomura; Y Fujii; Y Oshita
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

3.  Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats.

Authors:  J Sakurai; Y Oshita; Y Fujii
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

4.  Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta.

Authors:  Y Fujii; S Nomura; Y Oshita; J Sakurai
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

5.  Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets.

Authors:  J Naito; H Komatsu; A Ujiie; S Hamano; T Kubota; M Tsuboshima
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

6.  Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

7.  Influence of phospholipase C on some electrical properties of the skeletal muscle membrane.

Authors:  E X Albuquerque; S Thesleff
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

8.  Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.

Authors:  C Ingerman-Wojenski; M J Silver; J B Smith; E Macarak
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Prostacyclin production in rabbit arteries in situ: inhibition by arachidonic acid-induced endothelial cell damage or by low-dose aspirin.

Authors:  C Ingerman-Wojenski; M J Silver; J B Smith; M Nissenbaum; A W Sedar
Journal:  Prostaglandins       Date:  1981-04

10.  Phospholipidcholesterol membrane model. Control of resistance by ions or current flow.

Authors:  J M TOBIAS; D P AGIN; R PAWLOWSKI
Journal:  J Gen Physiol       Date:  1962-05       Impact factor: 4.086

View more
  15 in total

1.  Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens.

Authors:  I Guillouard; T Garnier; S T Cole
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells.

Authors:  J D Firth; E E Putnins; H Larjava; V J Uitto
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 3.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

4.  Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.

Authors:  M Nagahama; T Nakayama; K Michiue; J Sakurai
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Cloning, characterization, and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae.

Authors:  A E Fiore; J M Michalski; R G Russell; C L Sears; J B Kaper
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Authors:  Philipp Aurass; Maren Schlegel; Omar Metwally; Clare R Harding; Gunnar N Schroeder; Gad Frankel; Antje Flieger
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

7.  Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes.

Authors:  J Sakurai; S Ochi; H Tanaka
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.

Authors:  R W Titball; D L Leslie; S Harvey; D Kelly
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  Evidence for coupling of Clostridium perfringens alpha-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes.

Authors:  J Sakurai; S Ochi; H Tanaka
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.

Authors:  M Ninomiya; O Matsushita; J Minami; H Sakamoto; M Nakano; A Okabe
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.